Evaluation on the effect of TCM Syndrome Differentiation and Treatment based on community/isolated population in preventing novel coronavirus pneumonia (COVID-19)

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042314

Enrollment

Unknown

Registered

2021-01-17

Start date

2021-01-17

Completion date

Unknown

Last updated

2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

1. Centralized isolation of people (suspected cases

close contacts

second-close contacts)

2. Home isolation and community groups.:Prevent Chinese Medicine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Target population over 18 years old; 2. On the basis of routine protection, agree to conduct syndrome differentiation and treatment, and be able to follow the plan to take drugs; 3. Volunteer to participate in this clinical observation.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to the known ingredients of the drug; 2. Those who cannot take preventive preparations; 3. People with mental disorders or combined with major diseases such as cardiovascular, respiratory system, liver, and kidney; 4. People who have reading ability barriers and cannot cooperate with data collection; 5. Others who are not suitable to participate in this study.

Design outcomes

Primary

Measure	Time frame
Confirmed 2019-ncov pneumonia;	—

Secondary

Measure	Time frame
TCM symptoms;	—

Countries

China

Contacts

Public ContactWang Tan

Affiliated Hospital of Changchun University of Traditional Chinese Medicine

Wangtan215@sina.com+86 13756858523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026